Humira tops list of drugs with unwarranted US price hikesAbbVie’s Humira heads a list of seven medicines that collectively contributed to a $5.1 billion increase in US Share XHumira tops list of drugs with unwarranted US price hikeshttps://pharmaphorum.com/news/humira-tops-list-of-drugs-with-unwarranted-us-price-hikes/
Pfizer’s Lyrica fails phase 3 trial in epilepsyPfizer’s Lyrica has failed to meet its primary endpoint in a phase 3 trial in primary generalised tonic-clonic Share XPfizer’s Lyrica fails phase 3 trial in epilepsyhttps://pharmaphorum.com/news/pfizers-lyrica-fails-phase-3-trial-in-epilepsy/
